Middle East and Africa Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form; Drug Class; Distribution Channel

The Middle East and Africa antacids market is expected to reach US$ 659.18 million in 2027 from US$ 522.04 million in 2019. The market is estimated to grow at a CAGR of 3.0% during 2020-2027.

The growth the Middle East and Africa antacids market is attributed to the key driving factors such as the rising prevalence of gastroesophageal reflux disease (GERD) and increasing prevalence of obesity. However, the lack of awareness associated with gastrointestinal disorders in low-income economies hinders the market growth.

Gastroesophageal reflux disease (GERD), a digestive disorder that affects the ring of muscle between esophagus and stomach, is a chronic and highly prevalent disorder. As per the report ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014, the prevalence of GERD is 8.7-33.1% in the Middle East.

Furthermore, as per the survey, 18% of the 71,000 people reported the episodes of GERD twice a week and 31% reported GERD episodes once a week. The survey also reported that 35% of these patients used medications to control the condition and 55% of these used proton-pump inhibitors as their medication therapy. Additionally, the survey reported that the condition is more prevalent in women than in men. Thus, the rise in prevalence of gastroesophageal reflux disease (GERD) is propelling the demand for antacids in the Middle East and Africa.

COVID-19 pandemic has become the most significant challenge in the Middle East and Africa. Owing to the reducing imports due to disruptions in global trade, there is an increase in the shortages of medical supplies and other goods that raises the prices of the same. The developing countries have registered a growth in the number of COVID-19 confirmed cases due to the rising population movement from one location to another within and outside the country. However, amid this pandemic, the antacid market in Middle East and Africa is expected to rise due to the increasing awareness about self-care, and antacids are prescribed as a medication for side effects associated with the consumption of various drugs, such as antibiotics and antivirals. The region’s antacid market is expected to witness a higher demand for antacids during the pandemic.

Based on dosage form, the Middle East and Africa antacids market is segmented into tablet, liquid, and others. The tablet segment held the largest market share in 2019, whereas the liquid segment is anticipated to register the highest CAGR in the market during the forecast period.

The Middle East and Africa antacids market, based on drug class, is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. The proton pump inhibitors segment held the largest market share in 2019, also the same segment is anticipated to register the highest CAGR in the market during 2020-2027.

By distribution channel, the Middle East and Africa antacids market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest market share in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa antacids market are World Health Organization (WHO), and ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014.